前列腺癌放疗临床结局预测工具的系统评价
该系统评价检索PubMed与EMBASE(2007年7月起),纳入47篇文献,描述66个新开发模型与31个外部验证,共涉及60,457例1984至2009年间招募的患者。结果显示65%的模型未做外部验证、57%未报告准确性、31%使用了现有数据集难以获取的变量;多数模型针对外照射放疗,近距离放疗相关工具稀缺。
要点
- 65%的预测模型未做外部验证,57%未报告准确性。
- 31%的模型使用了现有数据集中难以获取的变量。
- 74%(72个)模型针对外照射放疗,近距离放疗工具稀缺。
核心结论
- 近期文献共描述97个预后模型,较既往综述(17篇,1966-2007年)明显增多,但多数未经验证,且部分使用难以获取的变量。
- 已有经过验证且准确的外照射放疗后前列腺癌特异性死亡预测模型,但近距离放疗相关工具稀缺。
研究设计与样本
- 系统评价,检索PubMed与EMBASE(2007年7月起),由两名评价者完成题录与摘要筛选、全文审阅及批判性评价,检索前已发表综述方案。
- 检索得到165篇潜在文献,72篇进入全文审阅,最终纳入47篇,描述66个新开发模型和31个外部验证。
- 纳入研究共涉及60,457例患者,招募时间为1984年至2009年。
主要发现
- 65%的模型未做外部验证,57%未报告准确性,31%包含现有数据集中不易获取的变量。
- 72个(74%)模型与外照射放疗相关,其余与近距离放疗(单独或联合外照射)相关。
- 已开展验证的研究多限于美国单一机构的数据。
临床怎么用
- 本综述提供当前可用的预测工具目录,可供临床参考并作为未来优先验证的对象。
局限性
- 多数模型缺乏外部验证,验证多限于美国单一机构数据,且部分模型变量在现有数据集中不易获取。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Prostate cancer can be treated with several different modalities, including radiation treatment. Various prognostic tools have been developed to aid decision making by providing estimates of the probability of different outcomes. Such tools have been demonstrated to have better prognostic accuracy than clinical judgment alone. METHODS: A systematic review was undertaken to identify papers relating to the prediction of clinical outcomes (biochemical failure, metastasis, survival) in patients with prostate cancer who received radiation treatment, with the particular aim of identifying whether published tools are adequately developed, validated, and provide accurate predictions. PubMed and EMBASE were searched from July 2007. Title and abstract screening, full text review, and critical appraisal were conducted by two reviewers. A review protocol was published in advance of commencing literature searches. RESULTS: The search strategy resulted in 165 potential articles, of which 72 were selected for full text review and 47 ultimately included. These papers described 66 models which were newly developed and 31 which were external validations of already published predictive tools. The included studies represented a total of 60,457 patients, recruited between 1984 and 2009. Sixty five percent of models were not externally validated, 57% did not report accuracy and 31% included variables which are not readily accessible in existing datasets. Most models (72, 74%) related to external beam radiation therapy with the remainder relating to brachytherapy (alone or in combination with external beam radiation therapy). CONCLUSIONS: A large number of prognostic models (97) have been described in the recent literature, representing a rapid increase since previous reviews (17 papers, 1966-2007). Most models described were not validated and a third utilised variables which are not readily accessible in existing data collections. Where validation had occurred, it was often limited to data taken from single institutes in the US. While validated and accurate models are available to predict prostate cancer specific mortality following external beam radiation therapy, there is a scarcity of such tools relating to brachytherapy. This review provides an accessible catalogue of predictive tools for current use and which should be prioritised for future validation.
引用
- Raymond E, O'Callaghan ME, Campbell J, et al. An appraisal of analytical tools used in predicting clinical outcomes following radiation therapy treatment of men with prostate cancer: a systematic review. Radiat Oncol. 2017. PMID: 28327203. doi:10.1186/s13014-017-0786-z
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。